Egetis Therapeutics AB Statistics

Total Valuation

STO:EGTX has a market cap or net worth of SEK 1.31 billion. The enterprise value is 1.14 billion.

Market Cap	1.31B
Enterprise Value	1.14B

Important Dates

The last earnings date was Wednesday, April 30, 2025.

Earnings Date	Apr 30, 2025
Ex-Dividend Date	n/a

Share Statistics

STO:EGTX has 359.24 million shares outstanding. The number of shares has increased by 19.69% in one year.

Current Share Class	359.24M
Shares Outstanding	359.24M
Shares Change (YoY)	+19.69%
Shares Change (QoQ)	+2.38%
Owned by Insiders (%)	15.01%
Owned by Institutions (%)	24.41%
Float	182.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	5.29
PS Ratio	28.08
PB Ratio	3.03
P/TBV Ratio	3.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.45
EV / Sales	24.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.79

Financial Position

The company has a current ratio of 1.53, with a Debt / Equity ratio of 0.25.

Current Ratio	1.53
Quick Ratio	1.51
Debt / Equity	0.25
Debt / EBITDA	n/a
Debt / FCF	-0.45
Interest Coverage	-13.42

Financial Efficiency

Return on equity (ROE) is -73.19% and return on invested capital (ROIC) is -35.14%.

Return on Equity (ROE)	-73.19%
Return on Assets (ROA)	-27.92%
Return on Invested Capital (ROIC)	-35.14%
Return on Capital Employed (ROCE)	-60.66%
Revenue Per Employee	1.23M
Profits Per Employee	-8.72M
Employee Count	40
Asset Turnover	0.07
Inventory Turnover	33.82

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.79% in the last 52 weeks. The beta is 1.08, so STO:EGTX's price volatility has been similar to the market average.

Beta (5Y)	1.08
52-Week Price Change	-41.79%
50-Day Moving Average	3.92
200-Day Moving Average	5.11
Relative Strength Index (RSI)	44.40
Average Volume (20 Days)	439,279

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:EGTX had revenue of SEK 46.70 million and -331.50 million in losses. Loss per share was -1.03.

Revenue	46.70M
Gross Profit	28.10M
Operating Income	-318.10M
Pretax Income	-331.20M
Net Income	-331.50M
EBITDA	-315.00M
EBIT	-318.10M
Loss Per Share	-1.03

Full Income Statement

Balance Sheet

The company has 272.80 million in cash and 106.50 million in debt, giving a net cash position of 166.30 million or 0.46 per share.

Cash & Cash Equivalents	272.80M
Total Debt	106.50M
Net Cash	166.30M
Net Cash Per Share	0.46
Equity (Book Value)	433.30M
Book Value Per Share	1.21
Working Capital	106.40M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -238.60 million and capital expenditures -400,000, giving a free cash flow of -239.00 million.

Operating Cash Flow	-238.60M
Capital Expenditures	-400,000
Free Cash Flow	-239.00M
FCF Per Share	-0.67

Full Cash Flow Statement

Margins

Gross Margin	60.17%
Operating Margin	-681.16%
Pretax Margin	-709.21%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

STO:EGTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.69%
Shareholder Yield	-19.69%
Earnings Yield	-25.28%
FCF Yield	-18.23%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

STO:EGTX has an Altman Z-Score of -0.67. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.67
Piotroski F-Score	n/a